首页> 外文期刊>The oncologist >Cetuximab May Inhibit Tumor Growth and Angiogenesis Induced by Ionizing Radiation: A Preclinical Rationale for Maintenance Treatment After Radiotherapy
【24h】

Cetuximab May Inhibit Tumor Growth and Angiogenesis Induced by Ionizing Radiation: A Preclinical Rationale for Maintenance Treatment After Radiotherapy

机译:西妥昔单抗可能抑制电离辐射诱导的肿瘤生长和血管生成:放疗后维持治疗的临床前理由

获取原文
获取外文期刊封面目录资料

摘要

>Background. The benefits of radiotherapy and cetuximab have encouraged evaluation of cetuximab after radiotherapy. The aims of this study were to preclinically evaluate the efficacy of cetuximab maintenance after radiotherapy and eventually determine its mechanisms of action.
机译:>背景。放疗和西妥昔单抗的益处鼓励了放疗后对西妥昔单抗的评估。这项研究的目的是临床前评估放疗后西妥昔单抗维持的疗效,并最终确定其作用机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号